CU23404A1 - Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes - Google Patents
Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantesInfo
- Publication number
- CU23404A1 CU23404A1 CU20030270A CU20030270A CU23404A1 CU 23404 A1 CU23404 A1 CU 23404A1 CU 20030270 A CU20030270 A CU 20030270A CU 20030270 A CU20030270 A CU 20030270A CU 23404 A1 CU23404 A1 CU 23404A1
- Authority
- CU
- Cuba
- Prior art keywords
- polysaccharides
- formulations
- neisseria meningitidis
- meningitidis
- similar
- Prior art date
Links
- 241000588650 Neisseria meningitidis Species 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000004676 glycans Chemical class 0.000 abstract 5
- 229920001282 polysaccharide Polymers 0.000 abstract 5
- 239000005017 polysaccharide Substances 0.000 abstract 5
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000007911 parenteral administration Methods 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000002434 immunopotentiative effect Effects 0.000 abstract 1
- 230000000091 immunopotentiator Effects 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229940021747 therapeutic vaccine Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20030270A CU23404A1 (es) | 2003-11-19 | 2003-11-19 | Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes |
| ARP040104182A AR046840A1 (es) | 2003-11-19 | 2004-11-12 | Polisacaridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes |
| PCT/CU2004/000014 WO2005049076A1 (fr) | 2003-11-19 | 2004-11-18 | Utilisation de polysaccharides capsulaires de neisseria meningitidis en tant que immunopotentialisateurs administres par voie muqueuse et formulations obtenues |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20030270A CU23404A1 (es) | 2003-11-19 | 2003-11-19 | Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23404A1 true CU23404A1 (es) | 2009-08-04 |
Family
ID=34777988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20030270A CU23404A1 (es) | 2003-11-19 | 2003-11-19 | Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR046840A1 (fr) |
| CU (1) | CU23404A1 (fr) |
| WO (1) | WO2005049076A1 (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7648997B2 (en) | 2003-08-12 | 2010-01-19 | Coley Pharmaceutical Group, Inc. | Hydroxylamine substituted imidazoquinolines |
| EP1658076B1 (fr) | 2003-08-27 | 2013-03-06 | 3M Innovative Properties Company | Imidazoquinolines substituees par aryloxy et arylalkyleneoxy |
| EP1660026A4 (fr) | 2003-09-05 | 2008-07-16 | 3M Innovative Properties Co | Traitement pour le lymphome a cellules b cd5+ |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| NZ546273A (en) | 2003-10-03 | 2009-05-31 | Coley Pharm Group Inc | Alkoxy substituted imidazoquinolines |
| AU2004291101A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Oxime substituted imidazo ring compounds |
| CA2545825A1 (fr) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Composes d'un anneau d'imidazo substitue par hydroxylamine |
| AR046781A1 (es) | 2003-11-25 | 2005-12-21 | 3M Innovative Properties Co | Derivados de imidazoquinolinas. composiciones farmaceuticas. |
| EP1701955A1 (fr) | 2003-12-29 | 2006-09-20 | 3M Innovative Properties Company | Imidazoquinolines a substitution arylalcenyle et arylalkynyle |
| WO2005066169A2 (fr) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle |
| EP1730143A2 (fr) | 2004-03-24 | 2006-12-13 | 3M Innovative Properties Company | Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide |
| WO2005123080A2 (fr) | 2004-06-15 | 2005-12-29 | 3M Innovative Properties Company | Imidazoquinolines et imidazonaphthyridines substituees par un heterocyclyle contenant un azote |
| WO2006009826A1 (fr) | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Thiazoloquinolines et thiazolonaphtyridines substitues par aryloxy et arylalkyleneoxy |
| US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| CN101443005A (zh) * | 2004-12-30 | 2009-05-27 | 科勒制药集团公司 | 免疫反应调节制剂和方法 |
| US8034938B2 (en) | 2004-12-30 | 2011-10-11 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| CA2592904C (fr) | 2004-12-30 | 2015-04-07 | 3M Innovative Properties Company | Composes chiraux a cycle [1,2]imidazo[4,5] fusionne |
| AU2006210392A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune response modifiers |
| CA2597587A1 (fr) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes |
| WO2006107851A1 (fr) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Composes cycliques 1-pyrazolo[3,4-c] substitues comme modulateurs de la biosynthese de cytokine destines au traitement d'infections virales et de maladies neoplastiques |
| JP2008535832A (ja) | 2005-04-01 | 2008-09-04 | コーリー ファーマシューティカル グループ，インコーポレイテッド | ピラゾロピリジン−１，４−ジアミン、およびそのアナログ |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| CN101785857B (zh) * | 2010-03-05 | 2012-09-26 | 成都安特金生物技术有限公司 | 一种新的肺炎球菌结合疫苗及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2375704T5 (es) * | 2000-06-29 | 2016-03-03 | Smithkline Beecham Biologicals S.A. | Composición de vacuna multivalente |
-
2003
- 2003-11-19 CU CU20030270A patent/CU23404A1/es unknown
-
2004
- 2004-11-12 AR ARP040104182A patent/AR046840A1/es unknown
- 2004-11-18 WO PCT/CU2004/000014 patent/WO2005049076A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AR046840A1 (es) | 2005-12-28 |
| WO2005049076A1 (fr) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23404A1 (es) | Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes | |
| CY1115308T1 (el) | Συνθεσεις εμβολιου οι οποιες περιεχουν ανοσοενισχυτικο εκδοχο σαπωνινης | |
| EP3058954A3 (fr) | Compositions immunogènes et procédés | |
| ATE503493T1 (de) | Influenza vakzinzusammensetzungen zur intradermaler verabreichung | |
| MX2018013640A (es) | Liposomas pegiladas y metodos de uso. | |
| MX340096B (es) | Formulaciones de vacuna meningococica. | |
| CY1118732T1 (el) | Εμβολια κυστιδιων βασει gna1870 για προστασια ευρεως φασματος εναντι νοσων προκαλουμενων απο neisseria meningitidis | |
| PT1187629E (pt) | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador | |
| Riedl et al. | The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice | |
| WO2006060710A3 (fr) | Preparations de vaccins destinees a une administration intradermique, contenant des adjuvants et des agents antigeniques | |
| CY1111916T1 (el) | Εμβολιο ζωντανου εξασθενημενου ροταϊου για χορηγηση απο του στοματος | |
| CR10559A (es) | Vacuna de influenza | |
| DOP2009000239A (es) | Vacuna de influenza de emulsion de aceite en agua | |
| PE20190458A1 (es) | Composiciones de neisseria meningitidis y metodos de las mismas | |
| AR082952A1 (es) | Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis | |
| UY27843A1 (es) | Composicion de vacuna | |
| EA200601761A1 (ru) | Композиции в качестве адъювантов для усиления иммунных ответов на вакцины и способы их применения | |
| BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
| AR053661A1 (es) | Peptido para entregar vacunas via mucosas | |
| RU2008144180A (ru) | Вакцина против микоплазмы и prrsv | |
| AR038311A1 (es) | Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes | |
| AR059972A1 (es) | Administracion intranasal o inhalacional de virosomas | |
| UY28706A1 (es) | Proteoliposomas y sus derivados como adyuvantes inductores de respuesta citotóxica y las formulaciones resultantes | |
| AR046921A1 (es) | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes | |
| TH75448A (th) | พอลิแซคคาไรด์ที่เป็นปลอกหุ้มของ Neisseria meningitidis ในการเป็นตัวกระตุ้นภูมิคุ้มกันทางเยื่อบุเมือก และสูตรผสมผลลัพธ์ที่ได้ |